Skip to content
  1. Home
  2. Latest news
  3. Johnson & Johnson announces a $50 million commitment to support frontline health workers battling COVID-19
lede-Johnson & Johnson Announces a $50 Million Commitment to Support Frontline Health Workers Battling Covid-19.jpg

Johnson & Johnson announces a $50 million commitment to support frontline health workers battling COVID-19

The funds will be earmarked for assisting the doctors, nurses, midwives and community health workers who are working tirelessly to treat patients around the world during the novel coronavirus pandemic.

Johnson & Johnson has long been committed to supporting and championing frontline health workers who courageously deliver care to the most vulnerable patients around the world—it’s a legacy that dates as far back as the 1900s, when the company helped limit the spread of the 1918 Spanish flu by introducing the epidemic mask.

Most recently, the company announced a commitment of $250 million over 10 years toward inspiring, recruiting, training, retaining and mobilizing frontline health workers guided by the Johnson & Johnson Center for Health Worker Innovation.

Today, the Johnson & Johnson family of companies and the Johnson & Johnson Foundation are committing $50 million to support frontline health workers in the global fight against Covid-19.

Those at the front lines are our colleagues, family members, customers and partners—so we join the millions around the world who put them front and center right now, to support them as they provide care amidst COVID-19.
Michael Sneed

“Serving doctors, nurses and health workers is who we are and what we do—and has been since 1886. Those at the front lines are our colleagues, family members, customers and partners—so we join the millions around the world who put them front and center right now, to support them as they provide care amidst COVID-19,” says Michael Sneed, Executive Vice President, Global Corporate Affairs & Chief Communication Officer. “We are proud to focus our pandemic response donations on the needs of frontline health workers and make a $50 million commitment in addition to the $250 million commitment made earlier this year.”

Johnson & Johnson is proud to help serve those who endeavor tirelessly to help keep us safe in hospitals, clinics and homes around the world, especially during this novel coronavirus pandemic.

How Johnson & Johnson Is Responding to the COVID-19 Pandemic

Learn about the innovative ways the company is mobilizing to help combat the global outbreak caused by the novel coronavirus.

More from Johnson & Johnson

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

This scientist develops targeted treatments for cancer—here’s what drives and inspires him

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.